Calpain 2 knockdown promotes cell apoptosis and restores gefitinib sensitivity through epidermal growth factor receptor/protein kinase B/survivin signaling

Gefitinib, an epidermal growth factor receptor (EGFR)-specific drug, is effective for ~1 year, after which resistance is inevitable. Calpain 2 (CAPN2) is known to serve a role in the drug response and resistance in certain cancer therapies. However, the full function of CAPN2, particularly in non-sm...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ge, Fang, Tao, Chang, Meijia, Li, Jing, Hong, Qunying, Bai, Chunxue, Zhou, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111457/
https://www.ncbi.nlm.nih.gov/pubmed/30106446
http://dx.doi.org/10.3892/or.2018.6625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111457/
https://www.ncbi.nlm.nih.gov/pubmed/30106446
http://dx.doi.org/10.3892/or.2018.6625

Ejemplares similares